In the past week, COEP stock has gone down by -19.87%, with a monthly decline of -3.65% and a quarterly plunge of -30.36%. The volatility ratio for the week is 24.57%, and the volatility levels for the last 30 days are 9.92% for Coeptis Therapeutics Holdings Inc The simple moving average for the past 20 days is -8.42% for COEP’s stock, with a 38.54% simple moving average for the past 200 days.
Is It Worth Investing in Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) Right Now?
Company’s 36-month beta value is -0.63.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for COEP is 2.93M, and currently, short sellers hold a 1.22% ratio of that floaft. The average trading volume of COEP on April 29, 2025 was 70.50K shares.
COEP) stock’s latest price update
Coeptis Therapeutics Holdings Inc (NASDAQ: COEP)’s stock price has soared by 16.49 in relation to previous closing price of 7.70. Nevertheless, the company has seen a loss of -19.87% in its stock price over the last five trading days. prnewswire.com reported 2025-04-28 that NEW YORK, April 28, 2025 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP ), relating to the proposed merger with Z Squared Inc. Under the terms of the agreement, holders of outstanding Z Squared shares will receive equity in Coeptis in exchange for 9,000 U.S. based dogecoin mining machines.
COEP Trading at -11.93% from the 50-Day Moving Average
After a stumble in the market that brought COEP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.53% of loss for the given period.
Volatility was left at 9.92%, however, over the last 30 days, the volatility rate increased by 24.57%, as shares sank -4.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.28% lower at present.
During the last 5 trading sessions, COEP fell by -19.87%, which changed the moving average for the period of 200-days by +59.04% in comparison to the 20-day moving average, which settled at $9.79. In addition, Coeptis Therapeutics Holdings Inc saw 63.09% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for COEP
Current profitability levels for the company are sitting at:
- -5.4 for the present operating margin
The net margin for Coeptis Therapeutics Holdings Inc stands at -5.27. The total capital return value is set at -2.29. Equity return is now at value -226.63, with -114.02 for asset returns.
Based on Coeptis Therapeutics Holdings Inc (COEP), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at -5.6. The debt to equity ratio resting at 0.37. The interest coverage ratio of the stock is 25.38.
Currently, EBITDA for the company is -10.05 million with net debt to EBITDA at -0.06. When we switch over and look at the enterprise to sales, we see a ratio of 16.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.23.
Conclusion
In a nutshell, Coeptis Therapeutics Holdings Inc (COEP) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
